US 10406146
Heterocyclic compound
granted A61KA61K31/454A61K31/4545
Quick answer
US patent 10406146 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/454, A61K31/4545, A61K31/5377, A61P